Activity of benzimidazoles againstDientamoeba fragilis(Trichomonadida, Monocercomonadidae)in vitroand correlation of beta-tubulin sequences as an indicator of resistance
Open Access
- 25 August 2014
- journal article
- research article
- Published by EDP Sciences in Parasite
- Vol. 21, 41
Abstract
Recently, Dientamoeba fragilis has emerged as a significant and common enteropathogen. The majority of patients with dientamoebiasis present with gastrointestinal complaints and chronic symptoms are common. Numerous studies have successfully demonstrated parasite clearance, coupled with complete resolution of clinical symptoms following treatment with various antiparasitic compounds. Despite this, there is very little in vitro susceptibility data available for the organism. Benzimidazoles are a class of antiparasitic drugs that are commonly used for the treatment of protozoan and helminthic infections. Susceptibility testing was undertaken on four D. fragilis clinical isolates against the following benzimidazoles: albendazole, flubendazole, mebendazole, nocodazole, triclabendazole and thiabendazole. The activities of the antiprotozoal compounds at concentrations ranging from 2 μg/mL to 500 μg/mL were determined via cell counts of D. fragilis grown in xenic culture. All tested drugs showed no efficacy. The beta-tubulin transcript was sequenced from two of the D. fragilis isolates and amino acid sequences predicted a susceptibility to benzimidazoles. This is the first study to report susceptibility profiles for benzimidazoles against D. fragilis, all of which were not active against the organism. This study also found that beta-tubulin sequences cannot be used as a reliable marker for resistance of benzimidazoles in D. fragilis.Keywords
This publication has 37 references indexed in Scilit:
- Towards the identification of the binding site of benzimidazoles to β-tubulin of Trichinella spiralis: Insights from computational and experimental dataJournal of Molecular Graphics and Modelling, 2013
- Symptoms and Treatment of Dientamoeba fragilis Infection in Children, a Retrospective StudyThe Pediatric Infectious Disease Journal, 2013
- The therapeutic journey of benzimidazoles: A reviewBioorganic & Medicinal Chemistry, 2012
- Detection and Transmission of Dientamoeba fragilis from Environmental and Household SamplesThe American Journal of Tropical Medicine and Hygiene, 2012
- In Vitro Susceptibility Testing of Dientamoeba fragilisAntimicrobial Agents and Chemotherapy, 2012
- Anthelmintic resistance: markers for resistance, or susceptibility?Parasitology, 2010
- Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2′-deoxyadenosineParasitology Research, 2010
- A Review of the Clinical Presentation of DientamoebiasisThe American Journal of Tropical Medicine and Hygiene, 2010
- Partial sequence of the beta-tubulin of Histomonas meleagridis and the activity of benzimidazoles against H. meleagridis in vitroParasitology Research, 2008
- Analysis of the β-Tubulin Gene from Vittaforma corneae Suggests Benzimidazole ResistanceAntimicrobial Agents and Chemotherapy, 2008